Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

NCT02518750 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Due to slow accrual

Conditions

Acute Lymphoblastic Leukemia
Lymphoma, Non-Hodgkin's
Leukemia, T-Cell
Leukemia, B-Cell

Interventions

DRUG: Dexamethasone
DRUG: Panobinostat
DRUG: Liposomal vincristine
DRUG: Mitoxantrone
DRUG: Peg-asparaginase
DRUG: Bortezomib
DRUG: Intrathecal Triples
DRUG: High-dose methotrexate
DRUG: 6-Mercaptopurine
DRUG: High-dose cytarabine
DRUG: Nelarabine
DRUG: Cyclophosphamide
DRUG: Etoposide
DRUG: Clofarabine

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]
[object Object]